Circulating calprotectin levels are associated with lung damage and disease outcome in patients with COVID-19.
- DOI
- 10.1080/17520363.2026.2752503
- Published
- 2026 Oct 22
- Container
- Biomarkers in medicine
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1080/17520363.2026.2752503,
title = {Circulating calprotectin levels are associated with lung damage and disease outcome in patients with COVID-19.},
author = {Belloni L and Bonacini M and Rossi A and Besutti G and Facciolongo N and Mezzadri S and Dolci G and Spaggiari L and Salvarani C and Croci S and Zerbini A},
year = {2026},
journal = {Biomarkers in medicine},
doi = {10.1080/17520363.2026.2752503},
url = {https://doi.org/10.1080/17520363.2026.2752503}
}RIS
TY - JOUR TI - Circulating calprotectin levels are associated with lung damage and disease outcome in patients with COVID-19. AU - Belloni L AU - Bonacini M AU - Rossi A AU - Besutti G AU - Facciolongo N AU - Mezzadri S AU - Dolci G AU - Spaggiari L AU - Salvarani C AU - Croci S AU - Zerbini A PY - 2026 JO - Biomarkers in medicine DO - 10.1080/17520363.2026.2752503 UR - https://doi.org/10.1080/17520363.2026.2752503 ER -
APA
L, B., M, B., A, R., G, B., N, F., S, M., G, D., L, S., C, S., S, C., & A, Z. (2026). Circulating calprotectin levels are associated with lung damage and disease outcome in patients with COVID-19.. Biomarkers in medicine. https://doi.org/10.1080/17520363.2026.2752503
Source records
- pubmed · retrieved 2026-11-10T16:43:16.272Z
- europe-pmc · retrieved 2026-11-10T16:43:16.286Z